According to a new report published by Allied Market Research, titled, "Russia In Vitro Fertilization Market by End User, Cycle Type, Type, Drug, and Mode of Administration: Opportunity Analysis and Industry Forecast, 2014-2022," the IVF market size inRussia was valued at $398 million in 2015, and is projected to reach $641 million by 2022, growing at a CAGR of 7.0% from 2016 to 2022. Non-assisted IVF cycles are projected to witness the highest growth rate from 2016 to 2022.
Access Full Summary at: https://www.alliedmarketresearch.com/russia-in-vitro-fertilization-IVF-market
In vitro fertilization (IVF) is an assisted reproductive technology (ART) that involves extraction of eggs, sample retrieval of sperm cells, followed by manual combination of an egg and sperm in laboratory settings to form an embryo. The embryo(s) is then transferred to the womans uterus for further gestation.
The Russia IVF market is driven by increase in incidence of infertility cases, emergent trend of delayed pregnancies among women, technological advancements in IVF procedures, and rise in gamete donation. However, insufficient reimbursement policies related to IVF treatment are anticipated to impede this growth. Moreover, growth in interest of single parents and same-sex couples to experience parenthood through ART, especially IVF, is expected to present various opportunities for market development.
The fertility clinics segment accounted for the highest share of the Russia IVF end user market in 2015, owing to the availability of wide range of fertility treatments under a single roof and applicable government reimbursements. The donor egg IVF cycle type segment is anticipated to witness the highest growth rate from 2016 to 2022. However, the fresh cycle (non-donor) is projected to dominate the cycle type market.
At present, gonadotropins & gonadotropin-releasing hormones dominate the drug segment of the market, and is expected to grow at a CAGR of 6.5% during the forecast period. This is attributable to the effectiveness and safety of this drug to stimulate ovulation during an IVF procedure.
Key Findings of the Russia In Vitro Fertilization (IVF) Market:
- The fertility clinics end-user segment is anticipated to grow at the highest CAGR from 2016 to 2022 in terms of value as well as volume.
- The fresh IVF cycle (non-donor) cycle type segment generated the highest revenue in 2015, and is expected to continue its dominance in the near future.
- ICSI assisted IVF cycles dominated the Russia in vitro fertilizationmarket, and are projected to grow at a CAGR of 6.4%.
- Donor egg IVF cycle type is expected to witness the highest growth rate in terms of value as well as volume during the forecast period.
The major companies profiled in the report include Ava-Peter Clinic, MD Medical Group, and IVF Russia (The International Centre of the Reproductive Medicines).